To sign up to receive Investor News as it is released please email Walbrook PR

18/07/18 VISITECT® CD4 commercialisation update
02/07/18 Notice of Results - RNS
28/06/18 Disposal of Infectious Disease Business
21/05/18 VISITECT CD4 Update
08/05/18 Allersys CE Mark
02/05/18 Closure of Omega Diagnostics GmbH
24/04/18 PDRM Dealing
24/04/18 Holding(s) in Company
23/04/18 Holding(s) in Company
23/04/18 Director/PDMR Shareholding
23/04/18 Holding(s) in Company
23/04/18 Director/PDMR Shareholding
20/04/18 Allersys Distributon Agreement
10/04/18 Strategic Review of Operations and Trading Update
10/04/18 Price Monitoring Extension
12/01/18 Holding(s) in Company
21/12/17 Allersys® CE-Mark
14/12/17 CEO Succession 
29/11/17 VISITECT® CD4 CE-Mark
01/11/17 Change of Registered Address
23/10/17 Trading Update and Notice of Interim Results
16/10/17 US Supply Agreement
10/10/17 Holding(s) in Company
05/09/17 Exercise of Options and Total Voting Rights
29/08/17 Result of AGM
18/07/17 Result of General Meeting
17/07/17 Result of Open Offer
06/07/17 Sale and leaseback of the building owned by Omega GmbH
30/06/17 Result of Proposed Fundraising
30/06/17 Proposed Fundraising
30/06/17 Final Results - FY17 
25/04/17 Trading Update and Notice of Results
21/04/17 Holding(s) in Company
29/03/17 VISITECT® Malaria CE-Mark and successful Indian FDA inspection
07/03/17 Holding(s) in Company
27/02/17 Holding(s) in Company
22/01/17 Update on discussions with Immunodiagnostic Systems Holdings plc
11/01/17 ISO accreditation for manufacturing facility in Pune, India
24/11/16 Holding(s) in Company
17/10/16 Trading Update and Notice of Interim Results
10/08/16 Result of AGM
02/08/16 R&D Grant Funding
04/07/16 Holding(s) in Company
01/07/16 Holding(s) in Company
27/06/16 Final Results - FY16
09/06/16 Holding(s) in Company
21/04/16 Trading Update and Notice of Results
08/02/16 Holding(s) in Company